Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion

Neurological Research

Volumn 29, Issue 3, 2007, Pages 274-282

  Yang, Dar Yu ^a,b   Pan, Hung Chuan ^a   Chen, Chun Jung ^a   Cheng, Fu Chou ^a   Wang, Yeou Chih ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cerebral ischemia; Collagen type IV; Fibronectin; Laminin; Matrix metalloproteinase; Microvessel; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; COLLAGEN TYPE 4; FIBRONECTIN; GELATINASE A; LAMININ; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BLOOD VESSEL INJURY; BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVATION; FIBRIN DEPOSITION; IMMUNOREACTIVITY; LOW DRUG DOSE; MALE; MEMBRANE DAMAGE; NONHUMAN; PROTEIN DEGRADATION; RAT; REPERFUSION; SPRAGUE DAWLEY RAT; VASCULAR TISSUE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 34249031789     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X159171     Document Type: Article

References (32)

1. Fieschi C, Argentino GL, Lenzi ML, et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989; 91: 311-322
2. Siesjö BK. Mechanisms of ischemic brain damage. Crit Care Med 1988; 16: 954-963
3. Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial-Europe Study Group. N Engl J Med 1996; 335: 145-150
4. controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke. Multicenter Acute Stroke Trial-Italy (MAST-I) Group. Lancet 1995; 346: 1509-1514
5. Gonner F, Remonda L, Mattle H, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998; 29: 1894-1900
6. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Study Group. N Engl J Med 1995; 333: 1581-1587
7. Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994; 25: 298-303
8. Tsuji K, Aoki T, Tejima F, et al. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 2005; 36: 1954-1959
9. Gulba DC, Bode C, Runge MS, et al. Thrombolytic agents - an overview. Ann Hematol 1996; 73: S9-S27
10. Werner RG, Bassarab S, Hoffman H, et al. Quality aspects of fibrinolytic agents based on biochemical characterization. Drug Res 1991; 41: 1196-1200
11. Kano T, Katayama Y, Tejima E, et al. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Brain Res 2000; 854: 245-248
12. Fagan SC, Garcia JH. Hemorrhagic transformation in focal cerebral ischemia: Influence of time-to-artery reopening and tissue plasminogen activator. Pharmacotherapy 1999; 189: 139-142
13. Chen ZL, Indyk JA, Strickland S. The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol Biol Cell 2003; 14: 2665-2676
14. Hamann GF, Okada Y, Fitridge R, et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995; 26: 2120-2126
15. Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab 1996; 16: 1373-1378
16. Hamann GF, Liebetrau M, Martens H, et al. Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab 2002; 22: 526-533
17. Yepes M, Sandkvist M, Wong MK, et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apotosis. Blood 2000; 96: 569-576
18. Zhang ZG, Zhang L, Tsang W, et al. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 2001; 912: 181-194
19. Horstmann S, Kalb P, Koziol J, et al. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: Influence of different therapies. Stroke 2003; 34: 2165-2170
20. Rosenberg GA, Navratil M, Barone F, et al. Proteolytic cascade enzyme increase in focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1996; 16: 360-366
21. Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinase expression after human cardioembolic strokes: Temporal profile and relation to neurological impairment. Stroke 2001; 32: 1759-1766
22. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002; 33: 831-836
23. Heo JH, Lucero J, Abumiya T, et al. Matrix metalloproteinases increases very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 1999; 19: 624-633
24. Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999; 842: 92-100
25. Nagai N, Urano T, Endo A, et al. Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection. Neurosci Res 1999; 33: 147-154
26. Mignatti P, Rifkin DB. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 1996; 49: 117-137
27. Okada Y, Copeland BR, Fitridge R, et al. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 1994; 25: 1847-1854
28. Wang YC, Lin CW, Shen CC, et al. Tissue plasminogen activator for the treatment of intraventricular hematoma: The dose-effect relationship. J Neurol Sci 2002; 202: 35-41
29. Benchenane K, Berezowski V, Fernández-Monreal M, et al. Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process. Stroke 2005; 36: 1059-1064
30. Liao SL, Chen WY, Raung SL, et al. Association of immune responses and ischemic brain infarction in rat. Neuroreport 2001; 12: 1943-1947
31. Milner R, Campbell IL. Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin. J Neurosci 2002; 22: 1562-1572
32. Rubin LL, Hall DE, Porter S, et al. A cell culture model of the blood-brain barrier. J Cell Biol 1991; 115: 1725-1735